P

Inventor

PELLICCIARI ROBERTO

IT67 patents
⚠️ This page may combine multiple inventors who share the name “PELLICCIARI ROBERTO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INTERCEPT PHARMACEUTICALS INC

26 patents
US9763964B2Sep 19, 2017

Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions

INTERCEPT PHARMACEUTICALS INC23 citations93
US8377916B2Feb 19, 2013

Steroids as agonists for FXR

INTERCEPT PHARMACEUTICALS INC15 citations93
US7812011B2Oct 12, 2010

Steroid agonist for FXR

INTERCEPT PHARMACEUTICALS INC18 citations93
US7786102B2Aug 31, 2010

Steroids as agonists for FXR

INTERCEPT PHARMACEUTICALS INC20 citations93
US7994352B2Aug 9, 2011

Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acid

INTERCEPT PHARMACEUTICALS INC22 citations92
US7932244B2Apr 26, 2011

Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions

INTERCEPT PHARMACEUTICALS INC24 citations92
US7858608B2Dec 28, 2010

Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions

INTERCEPT PHARMACEUTICALS INC21 citations92
US10532061B2Jan 14, 2020

Farnesoid X receptor modulators

INTERCEPT PHARMACEUTICALS INC5 citations84
US9732117B2Aug 15, 2017

Steroids as agonists for FXR

INTERCEPT PHARMACEUTICALS INC3 citations84
US9650409B2May 16, 2017

TGR5 modulators and methods of use thereof

INTERCEPT PHARMACEUTICALS INC4 citations84
US9611289B2Apr 4, 2017

Farnesoid X receptor modulators

INTERCEPT PHARMACEUTICALS INC13 citations84
US10421772B2Sep 24, 2019

Steroids as agonists for FXR

INTERCEPT PHARMACEUTICALS INC1 citations73
US9540414B2Jan 10, 2017

TGR5 modulators and methods of use thereof

INTERCEPT PHARMACEUTICALS INC4 citations73
US9243027B2Jan 26, 2016

TGR5 modulators and methods of use thereof

INTERCEPT PHARMACEUTICALS INC5 citations73
US11034717B2Jun 15, 2021

Farnesoid X receptor modulators

INTERCEPT PHARMACEUTICALS INC3 citations72
US9777038B2Oct 3, 2017

Process for preparing bile acid derivatives

INTERCEPT PHARMACEUTICALS INC3 citations72
US11345721B2May 31, 2022

TGR5 modulators and methods of use thereof

INTERCEPT PHARMACEUTICALS INC2 citations68
US10800807B2Oct 13, 2020

TGR5 modulators and methods of use thereof

INTERCEPT PHARMACEUTICALS INC3 citations68
US11066437B2Jul 20, 2021

Methods and intermediates for the preparation of bile acid derivatives

INTERCEPT PHARMACEUTICALS INC2 citations65
US11000532B2May 11, 2021

Farnesoid x receptor modulators

INTERCEPT PHARMACEUTICALS INC0 citations63
US8969330B2Mar 3, 2015

Steroids as agonists for FXR

INTERCEPT PHARMACEUTICALS INC2 citations63
US10987362B2Apr 27, 2021

Treatment of fibrosis using FXR ligands

INTERCEPT PHARMACEUTICALS INC0 citations62
US9090652B2Jul 28, 2015

Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions

INTERCEPT PHARMACEUTICALS INC3 citations62
US12291549B2May 6, 2025

Farnesoid X receptor modulators

INTERCEPT PHARMACEUTICALS INC0 citations61
US11319337B2May 3, 2022

3-desoxy derivative and pharmaceutical compositions thereof

INTERCEPT PHARMACEUTICALS INC0 citations61
US10815267B2Oct 27, 2020

3-desoxy derivative and pharmaceutical compositions thereof

INTERCEPT PHARMACEUTICALS INC1 citations61

PELLICCIARI ROBERTO

10 patents

GIULIANI SPA

4 patents

GIPHARMEX SPA

2 patents

LEHNER AG

2 patents

INTERCEPT PHARMACEUTICALS

1 patent

FIORUCCI STEFANO

1 patent

TES PHARMA S R L

1 patent

SEARLE & CO

1 patent

DEPHA TEAM SRL

1 patent

FIDIA SPA

1 patent

Showing the top 50 of 67 patents by PatentIndex Score.